Block XYZ 深 滬
已收盤 09-19 16:00:00 美东时间
77.03
-0.340
-0.44%
華盛通- 最 高77.71
- 今 開77.70
- 成交量 759.90万股
- 最 低 76.17
- 昨 收 77.37
- 總市值 469.88亿
- 52周最高 99.26
- 市盈率 靜 16.88
- 換手率 1.25%
- 52周最低 44.27
- 委 比 -94.35%
- 總股本 6.10亿
- 歷史最高 289.23
- 量 比 1.39
- 振 幅 1.99%
- 歷史最低 8.061
- 每 手 1
- 風險率
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Prism Johnson Secures Preferred Bidder Status for Limestone Block
Prism Johnson Limited ( ($IN:PRSMJOHNSN) ) just unveiled an update. Prism Johns...
09-20 23:03
Merck Scores Positive Feedback From EU Agency Regarding Blockbuster Cancer Drug
Merck received positive Keytruda notes from CHMP regarding its breakthrough cancer treatment with final decisions expected in late 2025.
09-20 03:07
'US Lurches Toward Shutdown as Senate Democrats Block GOP Stopgap'- Bloomberg
https://www.bloomberg.com/news/articles/2025-09-19/us-lurches-toward-shutdown-as-senate-democrats-block-gop-stopgap
09-20 01:45
Deal Dispatch: Need M&A Approval? FCC Chair Explains How To Get It
The "Jimmy Kimmel Live" drama coincided with reports of tit-for-tat maneuvering between the FCC and corporations desperate for deal approval.
09-19 23:58
“Farewell to Westphalia” Explores Blockchain as a Model for Post-Nation-State Governance
Zug, Switzerland, September 19th, 2025, Chainwire Logos Press Engine has announ...
09-19 21:30
Block Energy Launches Cost-Effective Drilling Pilot in Georgia
The latest announcement is out from Block Energy Plc ( ($GB:BLOE) ). Block Ener...
09-19 14:18
比特币资金跑了，澳大利亚监管机构放宽稳定币！
1 澳大利亚监管机构放宽对稳定币中介机构的监管规定 据Decrypt报道，澳大利亚证券与投资委员会（ASIC）已为稳定币中介机构提供监管豁免，允许它...
09-19 04:31
ResMed Stock: A Deep Dive Into Analyst Perspectives (9 Ratings)
Analysts' ratings for ResMed (NYSE:RMD) over the last quarter vary from bullish...
09-19 04:00
12 Information Technology Stocks Moving In Thursday's Intraday Session
Gainers Robot Consulting Co (NASDAQ:LAWR) shares rose 30.2% to $2.63 during Thu...
09-19 01:05
Telomir Pharma Study Shows Telomir-1 Blocks Cancer-Linked Gene Regulators In Lab Tests
Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) today announced new in vitro pharmacology results demonstrating that Telomir-1 potently inhibits three members of the KDM5 histone demethylase family. Histone demethylases are
09-18 19:35
